Analysis of MASTL expression in human tumors showed increased levels of the MASTL mRNA in breast cancer compared to normal tissue, correlating inversely with recurrence-free survival in ER-positive breast tumors (Fig. 6a and Supplementary Fig. S5). This evidence concerns the gene MASTL and breast cancer.